Autolus Therapeutics plc ADR (NASDAQ: AUTL) is 14.04% higher on its value in year-to-date trading and has touched a low of $2.07 and a high of $7.45 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AUTL stock was last observed hovering at around $2.63 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $2.68, the stock is 6.12% and -13.32% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.29 million and changing 1.90% at the moment leaves the stock -32.41% off its SMA200. AUTL registered -59.46% loss for a year compared to 6-month loss of -22.32%. The firm has a 50-day simple moving average (SMA 50) of $3.0919 and a 200-day simple moving average (SMA200) of $3.96495.
The stock witnessed a -16.25% gain in the last 1 month and extending the period to 3 months gives it a -31.28%, and is 16.52% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.20% over the week and 7.34% over the month.
Autolus Therapeutics plc ADR (AUTL) has around 463 employees, a market worth around $713.20M and $10.09M in sales. Profit margin for the company is -2677.90%. Distance from 52-week low is 29.47% and -64.03% from its 52-week high. The company has generated returns on investments over the last 12 months (-34.89%).
The EPS is expected to grow by 24.87% this year.
Autolus Therapeutics plc ADR (AUTL) Top Institutional Holders
The shares outstanding are 266.12M, and float is at 236.67M with Short Float at 3.25%.
The top institutional shareholder in the company is SYNCONA PORTFOLIO LTD with over 21.35 million shares valued at $74.29 million. The investor’s holdings represent 9.6083% of the AUTL Shares outstanding. As of 2024-06-30, the second largest holder is BLACKSTONE INC. with 20.49 million shares valued at $71.29 million to account for 9.2207 of the shares outstanding. The other top investors are WELLINGTON MANAGEMENT GROUP LLP which holds 17.89 million shares representing 8.0523% and valued at over $62.26 million, while DEEP TRACK CAPITAL, LP holds 6.8741 of the shares totaling 15.27 million with a market value of $53.15 million.
Autolus Therapeutics plc ADR (AUTL) Insider Activity
#####